Nikola Trbovic is a Managing Partner at SV Health Investors, focusing on building and funding biotech companies that develop transformative therapeutics. Leveraging his Ph. D. in Chemistry from Columbia University and prior experience at McKinsey, he brings extensive R&D, commercial, and strategic expertise to his board roles.
He was a board member at Therachon, a biotech company that was successfully acquired by pharmaceutical giant Pfizer.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.